Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005-2010

被引:32
作者
Alshaarawy, Omayma [1 ]
Anthony, James C. [1 ]
机构
[1] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48823 USA
关键词
NHANES; CRP; Cannabis smoking; Inflammation; Immunomodulation; MARIJUANA USE; INFLAMMATION; DISEASE; ATHEROSCLEROSIS; INTERLEUKIN-6; DISORDERS; BOOTSTRAP; OBESITY; DRUGS; MODEL;
D O I
10.1016/j.drugalcdep.2014.11.017
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Pre-clinical studies link cannabinoid-1 receptor activation to inflammation and atherosclerotic effects; anti-inflammation and immunosuppression seem to be mediated by cannabinoid-2 receptor activation. In this epidemiological study, we aim to present estimates on suspected cannabis-attributable immunomodulation as manifest in serum C-reactive protein (CRP) levels as non-specific inflammatory markers with interpretable clinical values. With strength of data from recent large nationally representative community sample surveys, the research approach illustrates value of a quantile regressions approach in lieu of the commonly used but relatively arbitrary cutpoints for CRP values. Methods: The study population encompasses 20-59 year old participants from the National Health and Nutrition Examination Surveys, 2005-2010 (n = 1115 recently active cannabis smokers and 8041 nonsmokers, identified via confidential Audio Computer Assisted Self-Interviews). Age, sex, race, education, income-poverty ratio, alcohol consumption, and tobacco smoking also were measured, together with body mass index (BMI), which actually might be on a mediational path. Quantile regressions, with boot-strapping for variance estimation, made it possible to hold these covariates constant while estimating cannabis-CRP associations. Results: Evidence suggesting possible cannabis-attributable immunomodulation emerges at CRP levels below the median (p < 0.05). Whereas BMI might help explain a cannabis link with serum CRP, but BMI-stratified analyses disclosed no appreciable variation of the cannabis-CRP relationship across BMI subgroups. Conclusions: Extending pre-clinical research on cannabis-attributable immunomodulation, this study's CRP evidence points toward possible anti-inflammatory effects of cannabis smoking. More definitive evidence can be derived by combining pre-clinical research, studies of patients, and epidemiological research approaches. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 37 条
[1]   Statistics notes - The cost of dichotomising continuous variables [J].
Altman, DG ;
Royston, P .
BRITISH MEDICAL JOURNAL, 2006, 332 (7549) :1080-1080
[2]   INVITRO AND INVIVO SUPPRESSIVE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL ON INTERFERON-PRODUCTION BY MURINE SPLEEN-CELLS [J].
BLANCHARD, DK ;
NEWTON, C ;
KLEIN, TW ;
STEWART, WE ;
FRIEDMAN, H .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (07) :819-824
[3]   Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: Linking obesity to vascular inflammation [J].
Calabro, P ;
Chang, DW ;
Willerson, JT ;
Yeh, ETH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :1112-1113
[4]   Inflammation and type 2 diabetes [J].
Calle, M. C. ;
Fernandez, M. L. .
DIABETES & METABOLISM, 2012, 38 (03) :183-191
[5]  
Campbell B, 2003, CLIN CHEM, V49, P201, DOI 10.1373/49.1.201
[6]   Estimation of Background Serum 2,3,7,8-TCDD Concentrations By Using Quantile Regression in the UMDES and NHANES Populations [J].
Chen, Qixuan ;
Garabrant, David H. ;
Hedgeman, Elizabeth ;
Little, Roderick J. A. ;
Elliott, Michael R. ;
Gillespie, Brenda ;
Hong, Biling ;
Lee, Shih-Yuan ;
Lepkowski, James M. ;
Franzblau, Alfred ;
Adriaens, Peter ;
Demond, Avery H. ;
Patterson, Donald G., Jr. .
EPIDEMIOLOGY, 2010, 21 :S51-S57
[7]   C-reactive protein and substance use disorders in adolescence and early adulthood: A prospective analysis [J].
Costello, E. Jane ;
Copeland, William E. ;
Shanahan, Lilly ;
Worthman, Carol M. ;
Angold, Adrian .
DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (02) :712-717
[8]   Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor-Deficient Mice [J].
Dol-Gleizes, Frederique ;
Paumelle, Rejane ;
Visentin, Virgile ;
Mares, Anne-Marie ;
Desitter, Perrine ;
Hennuyer, Nathalie ;
Gilde, Andries ;
Staels, Bart ;
Schaeffer, Paul ;
Bono, Francoise .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (01) :12-U40
[9]   1977 RIETZ LECTURE - BOOTSTRAP METHODS - ANOTHER LOOK AT THE JACKKNIFE [J].
EFRON, B .
ANNALS OF STATISTICS, 1979, 7 (01) :1-26
[10]   Wild bootstrap for quantile regression [J].
Feng, Xingdong ;
He, Xuming ;
Hu, Jianhua .
BIOMETRIKA, 2011, 98 (04) :995-999